Syndesi Therapeutics
Andrea is a pharmacologist and neuroscientist with 30 years of experience in CNS research, drug discovery and development. He spent more than 10 years at Evotec as SVP of CNS Preclinical Development and then acted as Senior CNS Consultant on the steering committee on a major collaboration in Alzheimer’s Disease. Prior to joining Evotec, Andrea was a Senior Scientist and Project Leader in the CNS research department at F. Hoffmann-La Roche Ltd, and Associate Director Pharmacology at Serono. Andrea contributed to several compounds that entered clinical development, including two drugs reaching Phase 2/3 in Alzheimer’s Disease. Andrea holds a PhD in Physiological and Pharmacological Sciences from the University of Milan.
This person is not in any offices
Syndesi Therapeutics
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.